Open AccessAnti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Author(s) -
Jie Mei,
Shaohua Li,
QiJiong Li,
Xuqi Sun,
Lianghe Lu,
Wenping Lin,
Lie Zheng,
Minshan Chen,
Ming Shi,
Wei Wei,
Rong Guo
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s298538
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , immunotherapy , chemotherapy , carcinoma , surgery , cancer
Hepatic artery infusion chemotherapy (HAIC) and anti-programmed cell death protein-1 (PD-1) immunotherapy have shown promising outcomes in patients with advanced hepatocellular carcinoma (HCC), respectively. However, the combination of the two treatments has not been reported. In this study, we compared the efficacy of HAIC combined with anti-PD-1 immunotherapy (HAICAP) and HAIC in patients with advanced HCC.